Characterization of CSP-1, a novel extended-spectrum β-lactamase produced by a clinical isolate of Capnocytophaga sputigena

29Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Capnocytophaga sputigena isolate NOR, responsible for septicemia, was resistant to amoxicillin and narrow-spectrum cephalosporins. In a cloning experiment, a new gene, blaCSP-1, was identified; this gene encodes a novel extended-spectrum β-lactamase (ESBL) that shares only 52% and 49% identities with the CME-1 and VEB-1 β-lactamases, respectively. The G+C content of this gene, its genetic environment, the absence of conjugation transfer, and its detection in two reference strains suggested that it was an intrinsic resistance gene located on the chromosome. Copyright © 2010, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Guillon, H., Eb, F., & Mammeri, H. (2010). Characterization of CSP-1, a novel extended-spectrum β-lactamase produced by a clinical isolate of Capnocytophaga sputigena. Antimicrobial Agents and Chemotherapy, 54(5), 2231–2234. https://doi.org/10.1128/AAC.00791-09

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free